• Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Rating of "Moderate Buy" from Brokerages

    Source: Buzz FX / 27 Feb 2025 03:01:20   America/New_York


    Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat February 27, 2025 Share Link copied to clipboard. Ionis Pharmaceuticals, Inc.
    Read more...
Share on,